Home » Topics » Regulatory » Patents

Patents
RSS

Celtaxsys divulges new LTA-4 hydrolase inhibitors

July 5, 2018

New Era Pharma presents Sgk1 and/or Sgk2 inhibitors

July 5, 2018

Jiangsu Nhwaluokang Pharmaceutical discovers allopregnanolone prodrugs

July 4, 2018

New P2X4 antagonists synthesized by Bayer

July 4, 2018

BeiGene identifies new PI3Kdelta inhibitors

July 4, 2018

Kalyra Pharmaceuticals patents amphotericin B derivatives as antifungals

July 4, 2018

Bionomics presents new nicotinic alpha7 receptor antagonists

July 4, 2018

Xenon Pharmaceuticals divulges Nav1.6 channel blockers

July 3, 2018

University of Texas System synthesizes MAP3K12 inhibitors

July 3, 2018

Merck & Co. presents FFA1 receptor agonists

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...